A carregar...

Clinical Outcomes with Use of Erythropoiesis Stimulating Agents in Patients with the HeartMate II Left Ventricular Assist Device

OBJECTIVES: We evaluated clinical outcomes associated with ESA use in LVAD-supported patients. BACKGROUND: Use of erythropoiesis stimulating agents (ESAs) in patients with left ventricular assist devices (LVADs) may minimize blood transfusions and decrease allosensitization. ESAs increase thrombotic...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JACC Heart Fail
Main Authors: Nassif, Michael E., Patel, Jayendrakumar S., Shuster, Jerrica E., Raymer, David S., Jackups, Ronald, Novak, Eric, Gage, Brian F., Prasad, Sunil, Silvestry, Scott C., Ewald, Gregory A., LaRue, Shane J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4766587/
https://ncbi.nlm.nih.gov/pubmed/25660839
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jchf.2014.08.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!